Advocates for Trans Equality (A4TE) is a transgender-rights advocacy organization dedicated to advancing the legal and political rights of transgender individuals in the United States. Formed in 2024 through the merger of the National Center for Transgender Equality (NCTE) and the Transgender Legal Defense and Education Fund (TLDEF), A4TE engages in public policy advocacy, impact litigation, political activity, research and data collection, and community organizing to advance its objectives.
A4TE has actively opposed federal and state legislation seeking to restrict transition-related medical interventions for minors. Including, organizing a coalition of more than 160 national and grassroots organizations that urged Congress to reject H.R. 3492, legislation which sought to establish federal criminal penalties for providing certain transition-related procedures to minors. A4TE characterized the targeted treatments as “safe and evidence-based” health care and argued that restrictions would interfere with medical decision-making.
A4TE references WPATH’s Standards of Care in support of transition-related medical care, despite the guidelines facing federal legal scrutiny. In June 2026, the FTC and four states sued WPATH, alleging misleading claims about the safety, effectiveness, and medical necessity of certain pediatric interventions.
Major corporations, including Apple, Amazon, Google, and Disney, have been identified as corporate partners of A4TE. Through these partnerships, companies may receive opportunities to engage directly with the organization while supporting its involvement in contentious social and public policy debates. These relationships raise questions about corporate accountability and the implications of supporting organizations that oppose legislative restrictions on transition-related medical interventions for minors.
As these treatments for minors face continued legal, medical, and political scrutiny, companies should consider the potential risks associated with such partnerships. Corporate leaders should evaluate whether supporting advocacy organizations involved in deeply contested policy debates advances their core business interests or instead creates unnecessary risks for their companies, shareholders, employees, and customers.